Transplantation of Human Pluripotent Stem Cell-Derived Cardiomyocytes for Cardiac Regenerative Therapy
Cardiovascular disease is the leading cause of death worldwide and bears an immense economic burden. Late-stage heart failure often requires total heart transplantation; however, due to donor shortages and lifelong immunosuppression, alternative cardiac regenerative therapies are in high demand. Hum...
Main Authors: | Sophia E. Silver, Ryan W. Barrs, Ying Mei |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-11-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2021.707890/full |
Similar Items
-
Metabolism of human pluripotent stem cells and differentiated cells for regenerative therapy: a focus on cardiomyocytes
by: Sho Tanosaki, et al.
Published: (2021-02-01) -
Toward the realization of cardiac regenerative medicine using pluripotent stem cells
by: Yoshikazu Kishino, et al.
Published: (2020-01-01) -
Bioengineering Clinically Relevant Cardiomyocytes and Cardiac Tissues from Pluripotent Stem Cells
by: Emma Claire James, et al.
Published: (2021-03-01) -
A Brief Review of Current Maturation Methods for Human Induced Pluripotent Stem Cells-Derived Cardiomyocytes
by: Razan Elfadil Ahmed, et al.
Published: (2020-03-01) -
Case report: Transplantation of human induced pluripotent stem cell-derived cardiomyocyte patches for ischemic cardiomyopathy
by: Shigeru Miyagawa, et al.
Published: (2022-08-01)